Mental Illness

This discussion delves into the profound influence of the brain on chronic health conditions, including various forms of pain, anxiety, and depression. Dr. Howard Schubiner, a distinguished internist and clinical professor, outlines his approach to understanding and treating these conditions, challenging conventional medical perspectives. His work highlights how the brain actively constructs our experiences, leading to symptoms that, while real, often lack a direct structural cause. This neuroplasticity offers a pathway to recovery, emphasizing the potential to retrain neural circuits and foster healing.

The conversation further explores therapeutic strategies designed to leverage the brain's capacity for change. Two primary methods, Pain Reprocessing Therapy (PRT) and Emotional Awareness and Expression Therapy (EAET), are presented as effective interventions. PRT focuses on re-educating the brain to interpret sensations differently, diminishing fear-based responses. EAET, on the other hand, guides individuals in safely processing and expressing deep-seated emotions, particularly those linked to past traumas, thereby addressing the emotional underpinnings of chronic symptoms. These approaches underscore a hopeful outlook, positing that many chronic conditions are reversible through targeted psychological interventions.

The Brain's Role in Symptom Generation and Neuroplasticity

Dr. Howard Schubiner's research and clinical practice underscore a transformative understanding of chronic pain, fatigue, anxiety, and depression. He posits that the brain is not merely a passive recipient of sensory information but an active creator of our experiences, a concept he refers to as predictive processing. This means that symptoms such as persistent back pain, even in the absence of ongoing physical injury, are often generated by the brain's protective mechanisms. The brain, constantly scanning for threats, can inadvertently create real physical or emotional discomfort as a danger signal, an insight that redefines the origins of many chronic conditions and opens new avenues for treatment beyond traditional medical orthodoxies.

Schubiner, influenced by Dr. Sarno's pioneering work on back pain, advocates for recognizing that emotional distress can manifest as physical symptoms, and vice versa. He illustrates how the brain's neural circuits can produce a range of symptoms, including pain, anxiety, and depression, which are not imagined but are actual experiences generated by the brain. This neuroplastic nature of symptoms implies that they are not necessarily permanent but are changeable. The challenge lies in distinguishing between structurally caused conditions and neuroplastic ones, with the latter offering significant potential for reversal through specific therapeutic interventions that aim to re-educate the brain and modify its predictive responses. This paradigm shift offers hope for individuals who have been told their conditions are incurable.

Therapeutic Approaches: Reprocessing Pain and Expressing Emotion

Two innovative therapeutic models, Pain Reprocessing Therapy (PRT) and Emotional Awareness and Expression Therapy (EAET), are central to Dr. Schubiner's methodology for addressing chronic conditions. PRT operates on the principle that neural pathways reinforced over time can be rewired. For instance, if anxiety is triggered by specific situations like driving, PRT helps individuals understand that these are learned neural circuits. By exposing the brain to these triggers in a controlled, safe environment and consciously reframing the experience with positive affirmations and calming techniques, the brain can learn to respond with less fear. This gradual desensitization and empowerment can lead to a significant reduction in symptoms, as the brain's learned danger responses are replaced with feelings of safety and control.

EAET focuses on the critical role of emotions in health and healing, especially for individuals with a history of trauma. Unlike methods that might re-traumatize, EAET guides individuals to safely activate and process emotions that may have been suppressed due to past experiences. This therapy teaches that emotions, including anger, sadness, and guilt, are not inherently dangerous but are natural responses that need healthy expression. By allowing individuals to revisit past traumas imaginatively, and then providing self-compassion and agency to their younger selves within that imagined scenario, EAET aims to change the neural circuits associated with traumatic memories. This deep, compassionate work helps individuals connect with their authentic selves, build resilience, and ultimately find recovery from neuroplastic conditions by addressing their emotional roots.

A recent investigation indicates that receiving the recombinant vaccine for shingles correlates with a reduced likelihood of developing dementia in elderly individuals who have recently been residents of skilled-nursing facilities. These findings imply that this standard immunization could provide protective advantages against cognitive deterioration over a four-year period. This research has been published in the Annals of Internal Medicine.

Shingles, a painful viral illness, results from the reawakening of the varicella-zoster virus, the same pathogen responsible for childhood chickenpox. The virus remains dormant within the nervous system and typically reactivates in adults over fifty or in those with compromised immune systems. Prior clinical studies have drawn a connection between shingles infection and an elevated risk of developing dementia later in life. Kaley Hayes, an associate professor and lead researcher at the Pharmacoepidemiology and Regulatory Evidence Lab, elaborated on the biological rationale behind their team's exploration of this connection. She noted that shingles increases the risk of stroke and general brain inflammation, suggesting that mitigating the activity of the herpes zoster virus might help prevent long-term brain damage and cognitive decline.

This study utilized extensive real-world data and a rigorous methodology, known as target trial emulation, to ascertain if the newer, more efficacious shingles vaccine offered similar protective benefits. The investigation focused on older adults admitted to skilled-nursing facilities, a demographic at high risk for both shingles and new-onset dementia. The team analyzed electronic health records linked to Medicare claims for over 500,000 individuals aged 66 or older, comparing vaccinated and unvaccinated groups over four years. They discovered that vaccinated participants had a 24% lower relative risk of being diagnosed with dementia, translating to a 5.8 percentage point absolute risk reduction. While the study suggests that up to 1 in 17 dementia cases might be prevented through shingles vaccination, it's crucial to acknowledge this is an association, not a direct cause-and-effect proof. Factors like 'healthy vaccinee bias' were considered, and even after adjustments, a 12% reduced risk remained.

While definitive randomized controlled trials are still needed to confirm these findings and exclude biases, the current evidence strongly suggests a significant association. The exact biological mechanisms behind this protective link are still under investigation, potentially involving reduced brain inflammation or prevention of toxic protein buildup associated with cognitive decline. Regardless, this research reinforces the importance of the shingles vaccine not only for preventing a painful ailment but also for its potential role in supporting long-term cognitive health in older populations.